about
Human T regulatory cell therapy: take a billion or so and call me in the morningTregalizumab - A Monoclonal Antibody to Target Regulatory T CellsResearch Progress on Regulatory T Cells in Acute Kidney InjuryDistinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cellsRegulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel functionGraft-versus-host disease: a surge of developmentsRegulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responsesPrinciples of adoptive T cell cancer therapy.TLR4 regulates IFN-γ and IL-17 production by both thymic and induced Foxp3+ Tregs during intestinal inflammationA panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells.Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly.Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cellsSTAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus.Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates."Regulating" rheumatoid arthritis via autotransplantation.Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome.Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cellsCD28 costimulation is essential for human T regulatory expansion and functionUnrelated umbilical cord blood transplantation and immune reconstitution.Assessing the in vitro suppressive capacity of regulatory T cells.Adoptive immunotherapy: good habits instilled at youth have long-term benefits.Post-transplant adoptive T-cell immunotherapy.Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes.Enhanced suppressive function of regulatory T cells from patients with immune-mediated diseases following successful ex vivo expansion.Role of STAT3 in regulatory T lymphocyte plasticity during acute graft-vs.-host-diseaseRegulatory T cells as immunotherapy.T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.Molecular mechanisms underlying Th1-like Treg generation and function.The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo.Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells.Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4(+)CD25 (+) T cells.Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.Gene Therapy With Regulatory T Cells: A Beneficial Alliance.Anti-inflammatory effects of Artemisia princeps in antigen-stimulated T cells and regulatory T cells.Immune Privilege and Eye-Derived T-Regulatory Cells.
P2860
Q24656069-90ACD758-26AF-41DA-8455-97F9A7869838Q26772699-3B10DE1F-0E48-42F8-9B86-5B49D1BF2B22Q26798141-1260727A-8A9A-4A1E-845E-AA2E39B63158Q27438176-C480AEFD-45B5-46C5-93EA-EBA3AA2C8CBCQ30819489-0BAD6EE1-6CF7-44AE-823F-31CB481FF023Q33290423-F2AE6914-D229-4879-9186-AE04B691D890Q33528964-9CFE2086-13E6-494C-B165-9DBF4089FBDCQ33867766-55D74AA7-A1C3-4908-A13E-0D03A4A33F89Q34003932-AD71F39D-93DA-4D20-AFD5-88E185FCF5D2Q34341325-9E987E94-EA4E-413C-829C-CB0B5E22F91CQ34365057-A9A49272-5EF1-4678-8EC8-0C3BD80BD724Q35514307-5D77C37B-15E2-48A7-ADFC-B54DEF4B1C63Q35553381-A94912B8-523A-44E8-8289-DA93FA7E92B6Q36127345-961BA099-9953-4221-965A-E1659D46B7F8Q36231545-18AB6077-9553-4794-9104-BEB9A1F67A93Q36316613-B2ADB221-09CA-4544-822C-D65D3D9FD4C8Q36551599-2B2F4C69-B892-43D6-8E0C-359A0B3DD029Q36638732-70D2F912-33FB-4CB9-BF7D-B134E0F81027Q36657964-53139316-3704-47A6-AD6D-5F3113FEF133Q36857515-08218B20-0218-4CC3-AA1A-C63E431A2F65Q36915913-07CA47B5-3707-43EA-9CCF-6979C635E7FCQ36916914-ED220DAC-311D-40FC-BBFB-B03EDD6E6279Q36934304-D4946A55-3970-4BBC-A8A0-899F7606F252Q37045670-FEEE55C3-50A5-40FD-9C0D-115CB52C1A03Q37257225-2324B024-6EE9-4753-B1D4-9DE1EFDAD75FQ37268318-AEB0DE37-ADEB-446E-AD49-EF7563CABB45Q37319692-EB8CDEE1-C628-4841-A0AE-51825E456865Q37477403-ED18BEF7-B275-4186-BC12-ADAA25F94341Q37529686-C0372742-1237-4D9F-935A-D22D8F6D0453Q38191610-591B0647-9724-4CB1-9BE2-A32F5FB8558FQ39017604-92140D1B-3F22-4FAA-A53B-45DA5974C3DCQ39380502-70E17D3A-CC0E-47AE-AD67-995F587C42EEQ42112037-79026A17-45A9-4BB0-B022-C55C46AE96BAQ42589743-61789F35-B316-40FE-9DEE-BCDC733999A7Q46022940-64231FEC-CED4-4C70-A2DE-D9F9A1559EE9Q51759591-F1D4B094-1489-4B36-ACE8-223B61A8F819Q52721830-8D98B12C-E1DE-45A5-93C9-847DCC71247EQ53498925-2C203FF3-06FF-4A16-809E-8CED285389FEQ55257332-B71E276F-6A84-40D0-82EA-8334B23F6C64
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Clinical application of expanded CD4+25+ cells.
@ast
Clinical application of expanded CD4+25+ cells.
@en
type
label
Clinical application of expanded CD4+25+ cells.
@ast
Clinical application of expanded CD4+25+ cells.
@en
prefLabel
Clinical application of expanded CD4+25+ cells.
@ast
Clinical application of expanded CD4+25+ cells.
@en
P1476
Clinical application of expanded CD4+25+ cells.
@en
P2093
Bruce R Blazar
Carl H June
P356
10.1016/J.SMIM.2006.01.006
P577
2006-02-02T00:00:00Z